NEVVI Medicare utilization intelligence
Compare this code with others
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS

Jump to the result views

G0249 Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the HCPCS · General Laboratory test
Classification Test › General Laboratory › Clinical Chemistry (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 1.56M services · est. ▼ 8.5% YoY · 106,807 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 779,062 observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Filter results:
Market summary
Market Brief G0249
A shareable PDF report summarizing this market’s size, trends, and providers.
Preview this Brief →

This market's Overview — its estimated all-Medicare volume, national benchmarks, and what the field charges and is paid — is part of Explore.

See what Medicare pays

An Explore subscription, $249 a seat a year, opens the Overview on every code, group and clinician page, including what the market charges and is paid.

It comes with 25 credits a seat a year for Deep Dives, which open the rest.

Subscribe to Explore →

Included in Explore. Part of a Deep Dive.
Continue from here

Browse Medicare billing by specialty →